Abbott in collaboration with health tech partners for diabetes care
08 February 2022 | News
The company aims to offer glucose monitoring solutions to 8 million people living with diabetes
Image Credit: Shutterstock
Abbott announced new collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher new era of holistic diabetes management care. Through these collaborations, Abbott aims to offer glucose monitoring solutions to 8 million people living with diabetes, of which approximately 6.5 million users can access through PharmEasy and 1MG.
The company is focussed on maintaining effective glucose levels along with remote consultations, diabetes-specific coaching, and dietary plans.
